• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CWWeekly Feb. 4th 2008 Issue

CWWeekly Feb. 4th 2008 Issue

February 8, 2008
CenterWatch Staff

Top News

Synarc Adds Hong Kong to List of Global Research Centers

San Francisco, Calif.-based contract research organization (CRO) Synarc launched a dedicated clinical research center in Hong Kong’s central district. The unit is more than 3,000 square-feet and operated by a dozen local staff members. A typical Synarc clinic is about 20,000 to 30,000 square-feet. Synarc conducts all its clinical trials at either its own sites or at sites run by partners. The company now owns 11 sites in Denmark, Estonia, Lithuania, Brazil, Romania, Poland, Czech Republic and mainland China.

PPD Breaks into China Central Lab Business

Wilmington, N.C.-based contract research organization (CRO) PPD made its first foray into the rapidly growing Chinese central laboratory market with the launch of its own unit, in cooperation with Peking Union Lawke Biomedical Development Limited (PUL). The exclusive agreement allows PPD to establish a commercial entity located on a separate campus near Peking Union Medical College Hospital (PUMCH). The facility is headed by Mayo Clinic–educated Jian Ho, M.D, Ph.D. The PUL has 60 highly trained local personnel.

Other breaking news...

Clinical Data signs agreement with Affymetrix...
Phase Forward reports strong growth...

Company Profile: An interview with Ibrahim Farr, MD, PhD, chief executive officer, Pivotal

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing